Journey Medical dermatology revenue plus Emrosi near-term sales and a rare pediatric disease PRV from Zycubo approval. See ...

The bills are dead for the second year in a row, but Sun Sentinel readers still want to speak out on a plan to allow closer collaboration between Broward’s two public hospital districts.

PITTSBURGH, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the fourth quarter and full year ending December 31, 2025 and ...

PIERRE — For the past five years, conversations about prisons and how to manage them have played out as one tumultuous bout ...

With this new indication, pitolisant is now approved to treat excessive daytime sleepiness, cataplexy, or both, in patients aged 6 years or older with narcolepsy.

New FDA approval for Wakix (pitolisant) allows for the treatment of cataplexy in pediatric narcolepsy patients.

Moby summary of Praxis Precision Medicines, Inc.'s Q4 2025 earnings call ...

Attorneys at Sidley Austin LLP examine the issue of drug price reporting rules under Medicaid and enforcement risks under the False Claims Act.

Travere Therapeutics (NASDAQ:TVTX) highlighted record demand for FILSPARI in IgA nephropathy (IgAN), provided an update on the U.S. Food and Drug Administration’s review timeline for a potential focal ...

Global rise in childhood hypertension linked to early heart changes. Experts call for routine screening and lifestyle action to protect young hearts.

An investigational oral medication conferred an increase in annualized height velocity at 1 year among children and ...

Q4 2025 Earnings Call February 19, 2026 4:30 PM ESTCompany ParticipantsCaitlin Lowie - Vice President of Corporate Communications ...